[HTML] springer.comFull View

[HTML][HTML] Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study

M Rinaldi, C Campoli, M Gallo, D Marzolla… - BMC Infectious …, 2023 - Springer
Purpose To investigate the clinical impact of three available antivirals for early COVID-19
treatment in a large real-life cohort. Methods Between January and October 2022 all …
被引用次数：1 相关文章
[HTML] biomedcentral.com

[HTML][HTML] Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study

M Rinaldi, C Campoli, M Gallo… - BMC Infectious …, 2023 - bmcinfectdis.biomedcentral.com
To investigate the clinical impact of three available antivirals for early COVID-19 treatment in
a large real-life cohort. Between January and October 2022 all outpatients tested positive for …

Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study

M Rinaldi, C Campoli, M Gallo, D Marzolla… - BMC INFECTIOUS …, 2023 - cris.unibo.it
Purpose: To investigate the clinical impact of three available antivirals for early COVID-19
treatment in a large real-life cohort. Methods: Between January and October 2022 all …

Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study.

M Rinaldi, C Campoli, M Gallo, D Marzolla, A Zuppiroli… - 2023 - cabidigitallibrary.org
Purpose: To investigate the clinical impact of three available antivirals for early COVID-19
treatment in a large real-life cohort. Methods: Between January and October 2022 all …
[PDF] scienceopen.com

[PDF][PDF] Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study

M Rinaldi, C Campoli, M Gallo, D Marzolla, A Zuppiroli… - 2023 - scienceopen.com
Purpose To investigate the clinical impact of three available antivirals for early COVID-19
treatment in a large real-life cohort. Methods Between January and October 2022 all …

Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study

M Rinaldi, C Campoli, M Gallo… - BMC Infectious …, 2023 - search.proquest.com
Purpose To investigate the clinical impact of three available antivirals for early COVID-19
treatment in a large real-life cohort. Methods Between January and October 2022 all …

Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study.

M Rinaldi, C Campoli, M Gallo, D Marzolla… - BMC Infectious …, 2023 - europepmc.org
Purpose To investigate the clinical impact of three available antivirals for early COVID-19
treatment in a large real-life cohort. Methods Between January and October 2022 all …

Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study.

M Rinaldi, C Campoli, M Gallo… - BMC Infectious …, 2023 - search.ebscohost.com
Purpose: To investigate the clinical impact of three available antivirals for early COVID-19
treatment in a large real-life cohort. Methods: Between January and October 2022 all …
[HTML] nih.gov

[HTML][HTML] Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study

M Rinaldi, C Campoli, M Gallo, D Marzolla… - BMC Infectious …, 2023 - ncbi.nlm.nih.gov
Purpose To investigate the clinical impact of three available antivirals for early COVID-19
treatment in a large real-life cohort. Methods Between January and October 2022 all …

Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study

M Rinaldi, C Campoli, M Gallo… - BMC infectious …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose To investigate the clinical impact of three available antivirals for early COVID-19
treatment in a large real-life cohort. Methods Between January and October 2022 all …